Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

SHIONOGI INC

Subsidiary ofSHIONOGI & COMPANY LIMITEDUEI: V8H8DT6RCHW6CAGE: 37UN1

SHIONOGI INC is a federal contractor, registered under UEI V8H8DT6RCHW6 and CAGE code 37UN1. It has been awarded $119,160,690 across 5 federal contracts. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology). Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

V8H8DT6RCHW6

CAGE Code

37UN1

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

202XMF

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)
424210Drugs and Druggists' Sundries Merchant Wholesalers

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Shionogi Inc. specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in the production and supply of clinical-grade drugs, hematology-related therapeutics, and specialty pharmaceuticals for federal healthcare systems. The company’s technical capabilities center ...

Shionogi Inc. specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in the production and supply of clinical-grade drugs, hematology-related therapeutics, and specialty pharmaceuticals for federal healthcare systems. The company’s technical capabilities center on GMP-compliant manufacturing processes, sterile product formulation, and quality assurance systems aligned with FDA and VA procurement standards. Their focus on hematology and drug delivery platforms suggests deep proficiency in complex dosage forms and controlled-release technologies, positioning them as a reliable source for mission-critical medications used in veteran care settings. Shionogi Inc. maintains a direct and focused relationship with the Department of Veterans Affairs, supplying pharmaceutical products under the Federal Supply Schedule for use in VA medical facilities. This engagement reflects a proven ability to meet the stringent regulatory, logistical, and dosing requirements of large-scale federal healthcare distribution networks, particularly for specialized therapeutics requiring consistent batch integrity and traceability. The contractor’s primary industry focus is NAICS 325412—Pharmaceutical Preparation Manufacturing—which encompasses the formulation, blending, packaging, and quality control of finished drug products intended for human use. Their market positioning is narrow but highly specialized, serving the niche segment of government-contracted pharmaceuticals where regulatory compliance, supply chain reliability, and therapeutic specificity are paramount. As a 2L entity headquartered in Florham Park, New Jersey, Shionogi Inc. operates as a corporate manufacturer with no active government certifications on record. Their geographic footprint is centered in the Northeast, with a federal market strategy anchored in direct supply to VA medical centers through established procurement channels. The company’s presence is defined by precision manufacturing and regulatory adherence rather than broad diversification across federal agencies.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Health And Human Services$119.2M100%
Awards by NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)$119.2M100%
Awards by Agency Over Time
Awards by Place of Performance

Open opportunities in SHIONOGI INC's top NAICS codes and agencies

NAICS: 541714
New
Federal
Hypobaric Chamber Pilot Studies
Solicitation # 80JSC026Q0006
NASA Johnson Space Center is soliciting offers for pilot chamber testing facilities capable of conducting hypobaric Decompression Sickness (DCS) studies under solicitation number 80JSC026Q0006, issued as a combined synopsis and solicitation per FAR Part 12 for commercial products and services. The requirement calls for three test days of data collection and recording following established research protocols, with detailed specifications outlined in Attachment A – Statement of Work and additional submission criteria in Attachment D dated July 15, 2026. The solicitation is open to all responsible sources without set-aside restrictions, and offerors must declare their size status under NAICS code 541714 with a 1,000-employee size standard. Evaluation of proposals will prioritize technical acceptability, followed by past performance, and then price, as specified in FAR 52.212-2. Offers must comply with applicable clauses including FAR 52.212-1, 52.212-2, and 52.212-4, as well as NASA-specific clauses such as the Ombudsman provision. All submissions must be delivered electronically to Tracy.L.Quintanilla@nasa.gov and Katelyn.R.Jaime@nasa.gov no later than August 24, 2026, at 1:00 p.m. Central Time. Questions must be submitted via email by July 29, 2026, same time, with no telephone inquiries accepted. Prospective offerors are encouraged to notify the point of contact of their intent to respond, and it is the offeror’s responsibility to download all documents from SAM.gov and ensure timely submission, as late or incomplete offers will be rejected in accordance with FAR provisions.
NASA Johnson Space Center

POSTED

5 days ago

DEADLINE

in 12 days
View Details